“sanofi” Archives

in
Entry Author Date Location
Cytokinetics Pivots to Another ALS Drug After Phase 3 Failure 11/21/17 San Francisco
Inozyme Gets $49M From Sanofi, Novo to Tackle Rare Infant Disease 11/15/17 Boston
Biotech Roundup: Opioid News, ASH Preview, Boston Bio IPOs & More 11/03/17 National
Sanofi Pulls Back from Voyager Gene Therapy Pact in Parkinson’s 10/31/17 Boston
Terminated Blood Cancer Drug Springs Back to Life at SD Biotech 10/26/17 San Diego
Eli Lilly to Pursue mRNA Cancer Vaccines with CureVac Pact 10/18/17 Indiana
Bio Roundup: Graham-Cassidy, Axovant Fail, SpringWorks Launches & More 09/29/17 National
Alnylam Data Puts a Nobel Discovery One Step Closer to Approved Drug 09/20/17 Boston
Race to Mine Fungi for Drugs Revs up as Verdine’s LifeMine Gets $55M 09/18/17 Boston
Regeneron Touts Success in Big Asthma Drug Study, Plans FDA Filing 09/11/17 New York
70% Repatha Cut? Amgen Counters With Own Study To Justify Price 08/23/17 National
WARF’s Erik Iverson Announces New VC Funds, Therapeutics Program 08/23/17 Wisconsin
Bio Roundup: Obamacare Persists, FDA Approves, Vertex Wows & More 07/21/17 National
Bio Roundup: PDUFA Progress, BCRA Redux, CAR-T Thumbs Up, & More 07/14/17 National
Sanofi Shores Up Flu Vaccine Business With Protein Sciences Deal 07/11/17 New York
Bio Roundup: Trumpcare Is Mean, SCOTUS Says Go, Merck’s Myeloma No 06/16/17 National
Amgen’s Heart Data Don’t Impress Drug-Price Evaluation Group 06/13/17 San Francisco
Bio Roundup: ASCO Combo Frenzy, Maine’s Free DNA Tests, Sema4 & More 06/02/17 National
Bio Roundup: Skinny Cuts, Genomic Approvals, Unfrozen FDA & More 05/26/17 National
Bio Leaders Mourn Passing of Genzyme Exec, Orphan Drug Innovator Termeer 05/14/17 Boston
Bio Roundup: Big Apple Mo’, Checkpoint Yes and No, CAR-T Death & More 05/12/17 National
Bio Roundup: Spinraza Woes, Science March, Baseline Launch & More 04/21/17 National
With Ovid IPO, Ex-Teva CEO Levin Pitches Neuro Drug Plan to Wall Street 04/11/17 New York
Bio Roundup: Gottlieb Talks Vax, Acorda’s Axe, Adams, 23andMe & More 04/07/17 National
With FDA Approval, Genentech Drug Becomes First For Severe MS Cases 03/29/17 San Francisco
FDA OKs Eczema Injection; Owners Regeneron, Sanofi Set $37K Price 03/28/17 New York
With New Data, Amgen Promises Refund If Cholesterol Drug Doesn’t Work 03/17/17 San Francisco
Harvard’s Verdine Aims to Retire, Become Full-Time FogPharma CEO 02/23/17 Boston
No Details Yet, But Amgen Touts Success in Big Heart Drug Study 02/02/17 San Francisco
Report: Biotech VCs Perpetuate Boardroom Gender Gap 01/24/17 National
Page 1 of 10 next page »